Clade Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 68

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $39.7M

  • Investors
  • 1

Clade Therapeutics General Information

Description

Developer of cell therapies designed to treat cancer, auto-immunity and other life-threatening diseases. The company combines stem cell biology, immunology, regenerative medicine, and gene editing to expand the impact of cell therapy, with an initial focus on developing therapies based on thymocytes and other immune cells, enabling clients to get stem cell-derived medicines.

Contact Information

Website
www.cladetx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 201 Brookline
  • Suite 1002
  • Boston, MA 02215
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 201 Brookline
  • Suite 1002
  • Boston, MA 02215
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clade Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 11-Apr-2024 $39.7M Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2022 Completed Startup
2. Early Stage VC (Series A) 30-Dec-2021 $87M $87M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Clade Therapeutics’s complete valuation and funding history, request access »

Clade Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Clade Therapeutics’s complete cap table history, request access »

Clade Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell therapies designed to treat cancer, auto-immunity and other life-threatening diseases. The company com
Drug Discovery
Boston, MA
68 As of 2024

Philadelphia, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clade Therapeutics Competitors (60)

One of Clade Therapeutics’s 60 competitors is Carisma Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Poseida Therapeutics Formerly VC-backed San Diego, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 60 competitors. Get the full list »

Clade Therapeutics Patents

Clade Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024270788-A1 Inhibiting natural killer cell cytotoxicity against cell therapies Pending 18-May-2023
AU-2024270788-A9 Inhibiting natural killer cell cytotoxicity against cell therapies Pending 18-May-2023
EP-4713365-A1 Inhibiting natural killer cell cytotoxicity against cell therapies Pending 18-May-2023
WO-2024238934-A1 Inhibiting natural killer cell cytotoxicity against cell therapies Inactive 18-May-2023
AU-2024218505-A1 Cd4 + and cd8 + single positive t cells and compositions and methods for generating the same Pending 08-Feb-2023 C12N5/0638
To view Clade Therapeutics’s complete patent history, request access »

Clade Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clade Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bristol-Myers Squibb Foundation Limited Partner Minority
Emerson Collective Impact Investing Minority
LifeSci Venture Partners Corporate Venture Capital Minority
Syncona Venture Capital Minority
Tech Launch Arizona Accelerator/Incubator
To view Clade Therapeutics’s complete investors history, request access »

Clade Therapeutics Acquisitions (1)

Clade Therapeutics’s most recent deal was a Merger/Acquisition with Gadeta. The deal was made on 02-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gadeta 02-Oct-2023 Merger/Acquisition Biotechnology
To view Clade Therapeutics’s complete acquisitions history, request access »

Clade Therapeutics FAQs

  • When was Clade Therapeutics founded?

    Clade Therapeutics was founded in 2020.

  • Where is Clade Therapeutics headquartered?

    Clade Therapeutics is headquartered in Boston, MA.

  • What is the size of Clade Therapeutics?

    Clade Therapeutics has 68 total employees.

  • What industry is Clade Therapeutics in?

    Clade Therapeutics’s primary industry is Drug Discovery.

  • Is Clade Therapeutics a private or public company?

    Clade Therapeutics is a Private company.

  • What is the current valuation of Clade Therapeutics?

    The current valuation of Clade Therapeutics is .

  • What is Clade Therapeutics’s current revenue?

    The current revenue for Clade Therapeutics is .

  • How much funding has Clade Therapeutics raised over time?

    Clade Therapeutics has raised $87M.

  • Who are Clade Therapeutics’s investors?

    Bristol-Myers Squibb Foundation, Emerson Collective, LifeSci Venture Partners, Syncona, and Tech Launch Arizona have invested in Clade Therapeutics.

  • Who are Clade Therapeutics’s competitors?

    Carisma Therapeutics, Poseida Therapeutics, Kite Pharma, Intellia Therapeutics, and Adaptimmune Therapeutics are some of the 60 competitors of Clade Therapeutics.

  • When was Clade Therapeutics acquired?

    Clade Therapeutics was acquired on 11-Apr-2024.

  • Who acquired Clade Therapeutics?

    Clade Therapeutics was acquired by Century Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process